Written By: Anamika Koshti, PharmD Reviewed By: Pharmacally Editorial Team Eli Lilly and Company has announced positive topline results from two pivotal Phase 3 studies of retatrutide, its investigational once-weekly triple hormone receptor agonist that targets glucose-dependent insulinotropic polypeptide (GIP), glucagon-like peptide-1 (GLP-1), and glucagon receptors
Compared with multiple ARBs in cluding candesartan, valsartan, azilsartan, eprosartan andirbesartan, only losartan has clear evidence of its ability to lower SUA level
Nature, 496 (7443), 110113
CVS Caremark announced on May 28, 2026 that its adding Foundayo on June 1 and restoring Zepbound on October 1 to its standard commercial formulary, which covers about 25 to 30 million Americans
After the session, most people are able to return to their normal activities right away
It functions as the primary intracellular antioxidant, donating electrons to neutralise reactive oxygen species (ROS) produced during mitochondrial respiration and inflammatory processes